Department of Microbiology, Tumor and Cell Biology (MTC), Karolinska Institutegrid.4714.6t, Stockholm Sweden.
Department of Molecular Medicine and Surgery, Karolinska Institutegrid.4714.6t, Rolf Luft Research Center for Diabetes and Endocrinology, Karolinska University Hospital, Stockholm, Sweden.
mBio. 2022 Oct 26;13(5):e0108622. doi: 10.1128/mbio.01086-22. Epub 2022 Sep 19.
Diabetes mellitus (DM) increases the risk of developing tuberculosis (TB), but the mechanisms behind diabetes-TB comorbidity are still undefined. Here, we studied the role of hypoxia-inducible factor-1 (HIF-1), a main regulator of metabolic and inflammatory responses, in the outcome of Mycobacterium tuberculosis infection of bone marrow-derived macrophages (BMM). We observed that M. tuberculosis infection of BMM increased the expression of HIF-1α and HIF-1-regulated genes. Treatment with the hypoxia mimetic deferoxamine (DFO) further increased levels of HIF-1-regulated immune and metabolic molecules and diminished the intracellular bacterial load in BMM and in the lungs of infected mice. The expression of HIF-1-regulated immunometabolic genes was reduced, and the intracellular M. tuberculosis levels were increased in BMM incubated with high-glucose levels or with methylglyoxal (MGO), a reactive carbonyl compound elevated in DM. In line with the findings, high M. tuberculosis levels and low HIF-1-regulated transcript levels were found in the lungs from hyperglycemic compared with wild-type mice. The increased intracellular M. tuberculosis growth and the reduced expression of HIF-1-regulated metabolic and inflammatory genes in BMM incubated with MGO or high glucose were reverted by additional treatment with DFO. -deficient BMM showed ablated responses of immunometabolic transcripts after mycobacterial infection at normal or high-glucose levels. We propose that HIF-1 may be targeted for the control of M. tuberculosis during DM. People living with diabetes who are also infected with M. tuberculosis are more likely to develop tuberculosis disease (TB). Why diabetic patients have an increased risk for developing TB is not well understood. Macrophages, the cell niche for M. tuberculosis, can express microbicidal mechanisms or be permissive to mycobacterial persistence and growth. Here, we showed that high glucose and carbonyl stress, which mediate diabetes pathogenesis, impair the control of intracellular M. tuberculosis in macrophages. Infection with M. tuberculosis stimulated the expression of genes regulated by the transcription factor HIF-1, a major controller of the responses to hypoxia, resulting in macrophage activation. High glucose and carbonyl compounds inhibited HIF-1 responses by macrophages. Mycobacterial control in the presence of glucose or carbonyl stress was restored by DFO, a compound that stabilizes HIF-1. We propose that HIF-1 can be targeted to reduce the risk of developing TB in people with diabetes.
糖尿病(DM)会增加患结核病(TB)的风险,但糖尿病与结核病合并症的机制仍不清楚。在这里,我们研究了缺氧诱导因子 1(HIF-1)在骨髓来源的巨噬细胞(BMM)感染结核分枝杆菌中的作用,HIF-1 是代谢和炎症反应的主要调节剂。我们观察到,结核分枝杆菌感染 BMM 会增加 HIF-1α和 HIF-1 调节基因的表达。用缺氧模拟物去铁胺(DFO)处理进一步增加了 HIF-1 调节的免疫和代谢分子的水平,并减少了 BMM 和感染小鼠肺部的细菌负荷。在高葡萄糖水平或在糖尿病中升高的反应性羰基化合物甲基乙二醛(MGO)孵育的 BMM 中,HIF-1 调节的免疫代谢基因的表达减少,细胞内结核分枝杆菌水平增加。与这些发现一致,与野生型小鼠相比,高血糖小鼠肺部的结核分枝杆菌水平升高,HIF-1 调节的转录物水平降低。在高葡萄糖或 MGO 孵育的 BMM 中,用 DFO 进一步处理可逆转细胞内结核分枝杆菌生长增加和 HIF-1 调节的代谢和炎症基因表达减少。在正常或高葡萄糖水平下感染分枝杆菌后,缺乏 HIF-1 的 BMM 的免疫代谢转录物反应消失。我们提出,HIF-1 可能是控制糖尿病期间结核分枝杆菌的靶点。患有糖尿病且又感染结核分枝杆菌的人更有可能患上结核病(TB)。为什么糖尿病患者患 TB 的风险增加尚不清楚。巨噬细胞是结核分枝杆菌的细胞栖息地,可以表达杀菌机制,也可以允许分枝杆菌的持续存在和生长。在这里,我们表明,介导糖尿病发病机制的高葡萄糖和羰基应激会损害巨噬细胞中细胞内结核分枝杆菌的控制。结核分枝杆菌感染刺激了转录因子 HIF-1 调节基因的表达,HIF-1 是缺氧反应的主要控制器,导致巨噬细胞活化。高葡萄糖和羰基化合物通过巨噬细胞抑制 HIF-1 反应。用 DFO 恢复了葡萄糖或羰基应激存在时的分枝杆菌控制,DFO 是一种稳定 HIF-1 的化合物。我们提出,HIF-1 可以作为靶点,降低糖尿病患者患 TB 的风险。